Issues
-
Actor James Woods seeks justice in brother’s wrongful death Tuesday, November 10, 2009
Michael Woods, actor James Woods’ brother, was sent for x-rays and returned to the emergency room, but all the treatment rooms were full, and his gurney was parked in the hallway. That’s where he died three years ago. A jury trial is opening in Mr. Woods’ death.
CONTINUE READING -
Feds failed to properly investigate Toyota defects Sunday, November 8, 2009
Despite 19 deaths and 1,000 owner complaints, federal investigations systematically excluded or dismissed the majority of complaints by owners that their Toyota and Lexus vehicles had suddenly accelerated, which sharply narrowed the scope of the probes.
CONTINUE READING -
Mercury Insurance’s George Joseph launches initiative war Friday, November 6, 2009
Stand back. Billionaire insurance executive George Joseph is launching what could become a new insurance initiative war.
CONTINUE READING -
Fiorini didn’t vote but did play politic$ Friday, November 6, 2009
Carly Fiorina didn’t vote but she and her husband made hefty campaign donations and her company, Hewlitt Packard, lobbied heavily.
CONTINUE READING -
Lobbying pays off for companies seeking stimulus money Friday, November 6, 2009
Dirt Diggers Digest: A frenzy of lobbying is paying off for companies seeking federal stimulus money.
CONTINUE READING -
Raj Rajaratnam played politics, like others in the hedge fund world Thursday, November 5, 2009
As often is the case, high-fliers in the financial world dabble in politics by dishing out campaign money. Hedge funds in particular have become involved, particularly in recent years as Congress contemplated — and generally backed off — imposing regulations and standards on the secretive industry.
CONTINUE READING -
How much influence does Big Pharma have at Harvard Medical School? Tuesday, November 3, 2009
Is it right for professors at Harvard Medical School to own stock in or accept speaking fees from pharmaceutical companies? The topic has been a hot one at Harvard since the revelation in summer 2008 that a child psychiatrist on the faculty had taken more than $1.6 million in payments from the maker of an antipsychotic drug he’d been prescribing.
CONTINUE READING